BlackRock
NMTC icon

BlackRock’s NeuroOne Medical Technologies NMTC Stock Holding History

BlackRock’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$24.8K Sell
24,029
-1,092
-4% -$2.05K ﹤0.01% 5440
2026
Q2 		$76.4K Buy
+25,121
New +$103K ﹤0.01% 5070

Other funds holding NMTC

Bleichroeder LP
Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Belpointe Asset Management
Belpointe Asset Management Reno, Nevada $3.63B AUM 17.81% 1-Year Est. Return

BlackRock's NMTC Position: Q3 2026 in Review

BlackRock reduced its NeuroOne Medical Technologies (NMTC) stake by 4.3% in Q3 2026, selling an estimated $2.05K and leaving 24,029 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5440.

BlackRock first reported a position in NMTC in Q2 2026 and has held it in 2 quarters since. The position peaked at $76.4K in Q2 2026. 18 funds tracked by Wall St. Rank hold NMTC as of Q3 2026.

  • BlackRock held 24,029 shares of NeuroOne Medical Technologies worth $24.8K as of Q3 2026.
  • BlackRock sold 1,092 NeuroOne Medical Technologies shares in Q3 2026, an estimated $2.05K.
  • NeuroOne Medical Technologies made up ﹤0.01% of BlackRock's portfolio in Q3 2026, its #5440 holding.
  • BlackRock first reported a position in NeuroOne Medical Technologies in Q2 2026 and has held it in 2 quarters since.
  • BlackRock's NeuroOne Medical Technologies position peaked at $76.4K in Q2 2026.
  • 18 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2026.

Based on BlackRock's 13F filing for Q3 2026, filed 13 Nov 2026.